<DOC>
	<DOCNO>NCT02699385</DOCNO>
	<brief_summary>The purpose study demonstrate domperidone suspension plus oral rehydration therapy ( ORT ) effective placebo plus ORT reduce symptom vomit associate acute gastroenteritis ( AG ) within first 48 hour treatment administration pediatric participant AG mild-to-moderate dehydration .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Domperidone Pediatric Participants With Nausea Vomiting Due Acute Gastroenteritis</brief_title>
	<detailed_description>This randomize ( study medication assign participant chance ) , double-blind ( neither researcher participant know treatment participant receiving ) , parallel-group , placebo-controlled , multicenter ( one hospital medical school team work medical research study ) study . The study consist 3 Phases : Screening Phase ( -2 0 hour prior baseline Day 1 ) , Double-blind treatment Phase ( 7 Days ) follow-up Phase ( 7 Days ) . The duration participation study participant 15 Days . Efficacy safety domperidone evaluate . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>The participant present least 3 episode nonbilious , nonbloody vomit within 24 hour prior visit physician 's office . The participant least 2 sign symptom vomit consistent acute gastroenteritis ( AG ) ( example , fever , nausea , diarrhea , abdominal pain , bloating , discomfort ) within 3 hour prior visit physician 's office The participant mildtomoderate dehydration The participant least 1 episode nonbloody diarrhea within 24 hour prior visit physician 's office The participant severe dehydration severe malnutrition The participant vomit clinical symptom longer 72 hour prior baseline physician 's office visit The participant need intravenous ( IV ) fluid replacement The participant chronic severe diarrhea , previous history Helicobacter pylorus infection receive treatment H. pyloriinduced gastritis , active peptic ulcer , celiac disease , Crohn 's disease , ulcerative colitis , eosinophilic esophagitis , malabsorption , short bowel syndrome , postviral gastroparesis , cyclic vomit syndrome , previous gastrointestinal surgery The participant upper respiratory symptom cough , congestion , otitis medium pharyngitis</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Gastroenteritis</keyword>
	<keyword>Domperidone</keyword>
	<keyword>Pediatric participant</keyword>
</DOC>